Prevalence of plasmid-mediated quinolone resistance

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 2, 2003, Pages 559-562

  Jacoby, George A ^a   Chow, Nancy ^a   Waites, Ken B ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); MICROCIN B17; NALIDIXIC ACID; PENTAPEPTIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE ISOLATION; GENE LOCATION; IMMUNITY; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN FAMILY; R PLASMID; UNITED STATES;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; R FACTORS;

EID: 0037309741     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.2.559-562.2003     Document Type: Article

References (16)

1. Ashraf, M. M., Z. U. Ahmed, and D. A. Sack. 1991. Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia. Can. J. Microbiol. 37:59-63.
2. Bateman, A., A. G. Murzin, and S. A. Teichmann. 1998. Structure and distribution of pentapeptide repeats in bacteria. Protein Sci. 7:1477-1480.
3. Garrido, M. C., M. Herrero, R. Kolter, and F. Moreno. 1988. The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J. 7:1853-1862.
4. Huovinen, S. 1988. Rapid isoelectric focusing of plasmid-mediated β-lactamases with Pharmacia PhastSyst. Antimicrob. Agents Chemother. 32:1730-1732.
5. Itokazu, G. S., J. P. Quinn, C. Bell-Dixon, F. M. Kahan, and R. A. Weinstein. 1996. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin. Infect. Dis. 23:779-784.
6. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
7. Lautenbach, E., B. L. Strom, W. B. Bilker, J. B. Patel, P. H. Edelstein, and N. O. Fishman. 2001. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33:1288-1294.
8. Lomovskaya, O., F. Kawai, and A. Matin. 1996. Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance. Antimicrob. Agents Chemother. 40:1050-1052.
9. Martinez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
10. Montero, C., G. Mateu, R. Rodriguez, and H. Takiff. 2001. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob. Agents Chemother. 45:3387-3392.
11. Munshi, M. H., D. A. Sack, K. Haider, Z. U. Ahmed, M. M. Rahaman, and M. G. Morshed. 1987. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet ii:419-421.
12. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard. NCCLS document M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Paterson, D. L., L. Mulazimoglu, J. M. Casellas, W. C. Ko, H. Goossens Von Gottberg, S. Mohapatra, G. M. Trenholme, K. P. Klugman, J. McCormack, and V. L. Yu. 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30:473-478.
15. Queenan, A. M., S. Jenkins, and K. Bush. 2001. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded β-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob. Agents Chemother. 45:3189-3194.
16. Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99:5638-5642.